Product Recalls in District of Columbia

Product recalls affecting District of Columbia — including food, drugs, consumer products, medical devices, and vehicles distributed to District of Columbia. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,635 recalls have been distributed to District of Columbia in the last 12 months.

47,654 total recalls
2,635 in last 12 months

Showing 49414960 of 13,355 recalls

DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.125% 125 Recalled by...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 1000 mcg/100 mL (10 mcg/mL) in 0.9% Sodium Chloride Preservative...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 500 mcg/250 mL (2 mcg/mL) 0.125% BUPivacaine HCl 312.5 Recalled by...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 400 mcg/200 mL (2 mcg/mL) 0.1% ROPivacaine HCl 200 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.1% 200 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 2500 mcg/50 mL (50 mcg/mL) 50 mL bag Recalled by QuVa Pharma, Inc....

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe Recalled by QuVa Pharma,...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride Recalled by...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 12, 2019· QuVa Pharma, Inc.

Recalled Item: fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride Recalled by QuVa...

The Issue: Presence of Particulate matter: manufacturer recalled fentanyl API due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 11, 2019· AuroMedics Pharma LLC

Recalled Item: Amiodarone Hydrochloride Injection Recalled by AuroMedics Pharma LLC Due to...

The Issue: Crystallization: Presence of visible particulate matter.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 11, 2019· AuroMedics Pharma LLC

Recalled Item: Amiodarone Hydrochloride Injection Recalled by AuroMedics Pharma LLC Due to...

The Issue: Crystallization: Presence of visible particulate matter.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 11, 2019· AuroMedics Pharma LLC

Recalled Item: Amiodarone Hydrochloride Injection Recalled by AuroMedics Pharma LLC Due to...

The Issue: Crystallization: Presence of visible particulate matter.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 11, 2019· AuroMedics Pharma LLC

Recalled Item: Lidocaine HCl Injection Recalled by AuroMedics Pharma LLC Due to Foreign...

The Issue: Presence of Foreign Substance: Foreign material found inside the vial.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 8, 2019· Med Man Distribution, Inc.

Recalled Item: UP2 Recalled by Med Man Distribution, Inc. Due to Undeclared Sildenafil

The Issue: Marketed without an Approved NDA/ANDA: Product contains undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 8, 2019· Washington Homeopathic Products, Inc.

Recalled Item: Ferrum Phosphoricum 6X Tablets Recalled by Washington Homeopathic Products,...

The Issue: CGMP Deviations: products were not manufactured under current good...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund